Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF PILL
Set alert
At close · Oct 30
After hours · Oct 30, 6:02 PM ET
- YTD
- +23.66%
- 1 year
- +75.84%
- Open
- 15.62
- Prev close
- 15.65
- Mkt cap
- 32.44M
- Vol
- 238.73K
- Avg vol
- 50.37K
- EPS
- 0.35853
- P/E
- 42.42
- Div yield
- 0.00%
More statistics
- Low
- 15.02
- High
- 15.84
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.83
- 200-d avg
- 7.64
5D chart
Signals (90)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:50 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 1 day ago |
| RSI: Oversold | Oct 30, 3:15 PM | 1 day ago |
| RSI: Oversold | Oct 30, 2:45 PM | 1 day ago |
| RSI: Oversold | Oct 30, 2:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:40 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 1:40 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 1:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:45 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:00 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 12:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 11:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:55 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:55 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:55 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:55 AM | 1 day ago |
| RSI: Overbought | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 2 days ago |
| RSI: Overbought | Oct 29, 3:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:15 PM | 2 days ago |
| RSI: Oversold | Oct 29, 1:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:40 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:15 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 3 days ago |
| RSI: Overbought | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:45 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 27, 2:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:35 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:45 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:50 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:45 PM | 5 days ago |
| RSI: Oversold | Oct 26, 3:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 12:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| RSI: Overbought | Oct 26, 12:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 5 days ago |
News
4 months ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 06/14/2026
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
9 months ago benzinga.com
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
10 months ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 12/14/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
11 months ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 11/16/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
11 months ago benzinga.com
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
1 year ago benzinga.com
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
1 year ago etftrends.com
As M&A Deals Rise, Can Biotech Pharma Break Loose?
After a relatively sluggish 2024 for mergers & acquisitions (M&A) activity in the biopharma sector, the environment could be more conducive for deals in the rest of 2025. The industry, like the rest…
1 year ago benzinga.com
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
1 year ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 08/17/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
1 year ago etftrends.com
CURE: Make an Adventurous Bet on an Undervalued Sector
The healthcare sector, the fifth-largest sector exposure in the S&P 500, was once a reliable destination for investors who wanted dependable performance without taking on significant risk. The group…
1 year ago benzinga.com
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
1 year ago benzinga.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
Barclays has said that it's hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.
1 year ago benzinga.com
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
1 year ago benzinga.com
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
1 year ago benzinga.com
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
1 year ago benzinga.com
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
2 years ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 07/28/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2 years ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 07/14/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2 years ago newsfilecorp.com
CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL)
Toronto, Ontario--(Newsfile Corp. - le 14 juin/June 2024) - The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024. Canntab Therapeutics…
2 years ago etftrends.com
Finding Opportunity in Unloved Healthcare ETFs
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
2 years ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 02/18/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2 years ago zacks.com
5 Best Leveraged ETFs of First Half of Q1
We highlight a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments in the first half of Q1.
2 years ago zacks.com
5 Best Inverse/Leveraged ETFs of Last Week
The optimism surrounding the likely Fed rate cuts in 2024 aided the rally in the market last week, barring some occasional dips.
3 years ago seekingalpha.com
Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
4 years ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 09/11/2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
4 years ago etftrends.com
Top Performing Leveraged/Inverse ETFs: 06/26/2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
4 years ago seekingalpha.com
Pharma In Transition: Context And Opportunities
The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.
4 years ago zacks.com
Best Leveraged ETF Areas of Last Week
Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.
5 years ago etftrends.com
3 ETFs to Access a Changing Pharmaceutical Industry
A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past…
5 years ago zacks.com
5 Best Leveraged ETFs of Last Week
Wall Street was overall upbeat last week. Though concerns about the spread of the Delta Variant of coronavirus worried investors, low rates boosted the demand for stock investments.